Inflammatory disorders

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Oncology & Cancer

Added corticosteroid deemed ineffective for cancer pain

(HealthDay)—The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online July 7 in the Journal of Clinical Oncology.

Medications

Disputed asthma drugs have safe record in British Columbia

A popular combination asthma therapy dogged by safety concerns has not harmed British Columbians and should remain in use, according to researchers at the University of British Columbia and Vancouver Coastal Health Research ...

Cardiology

Mortality predictors in CV implantable device infection ID'd

(HealthDay)—Infective endocarditis related to a cardiovascular implantable electronic device (CIED), corticosteroid therapy, and other comorbidities are tied to reduced short- and long-term survival, according to a study ...

Genetics

Data show five-year response for AAT deficiency gene therapy

Data demonstrating sustained protein expression five years after a single intramuscular injection of a gene-based therapy for the treatment of alpha-1 antitrypsin (AAT) deficiency also shows improvements in multiple indicators ...

page 2 from 3